Registration Open for Eyecelerator, a New Conference Aimed at Accelerating Eye Care Advancements

Source: ASCRS

Registration is now open for Eyecelerator, a new business conference aimed at furthering ophthalmic innovation. The conference is a joint venture between the American Academy of Ophthalmology (AAO) and the American Society of Cataract and Refractive Surgery (ASCRS). The inaugural Eyecelerator conference will be held on May 14 in Boston, in conjunction with the ASCRS annual meeting. The second Eyecelerator conference will be in November, in conjunction with the Academy’s annual meeting in Las Vegas.

Leaders from both organizations have created a conference that engages in unique ways inventors, investors, scientists, physicians, entrepreneurs, startups and established businesses, according to a company news release. Showcasing emerging technology, groundbreaking research and inventive concepts, the conference will act as the catalyst that propels innovation, transforming the future of ophthalmology.

The inaugural conference will feature a keynote address from Harvard Business School Professor Gary P. Pisano, a noted authority on the management of innovation and competitive strategy. His research and consulting experience span a range of industries, including biotechnology, pharmaceutical, healthcare, aerospace, and technology.

“We’re designing a dynamic schedule of programs focused on advancing state-of-the-art eye care at all stages of development, from emerging to market-ready, from VC-backed concepts to those seeking investors,” Eric D. Donnenfeld, MD, program co-chair, said in the news release. “We are also creating face-to-face and digital networking opportunities to create meaningful connections between attendees.”

Eyecelerator Conference I
Sheraton Boston
May 14, 2020
General – $600
ASCRS/Academy Members – $300

The one-day conference program includes presentations on:

  • Innovation for unmet clinical needs
  • Developing new category marketplaces
  • Recent clinical and financial milestones in innovation
  • Real world data: IRIS + MIGS
  • Combination product approvals
  • New markets, technology and capital sources outside the US
  • Wall Street view of ophthalmology markets
  • Pathways for growth from the next-generation strategics
  • Where innovation fits into industry consolidation

Complete and updated program and presenter information can be found at https://eyecelerator.com.

Related Content